It is therefore suggested that all CAYA HGG will be screened initially by immunohistochemistry for the mismatch repair proteins (PMS2, MSH6, MSH2, MLH1) to evaluate for loss of staining in both tumor and in case of CMMRD, adjacent normal tissue. The gene discussed is MSH2; the disease is neoplasm.